Thyroid cancer has its own general molecular profile (Pozdeyev et al. 2018, van der Tuin et al. 2019) with PI3K/AKT and RAS/ERK constituting major signaling pathways involved in thyroid tumorigenesis (Ricarte-Filho et al. 2009, Nikiforov 2011, Brehar et al. 2013, Xing 2013, Penna et al. 2016, Yarchoan et al. 2016). The gene discussed is AKT1; the disease is thyroid gland carcinoma.